The mRNA levels of transforming growth factor beta (TGF-β) and Foxp3 were lower in the CDI than those in the control group, and butyrate treatment increased TGF-β and Foxp3 mRNA levels (Fig. S3B). The gene discussed is FOXP3; the disease is clostridium difficile infection.